Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
675 McDonnell Blvd.
St. Louis, MO 63042
Radiopharmaceuticals and Tracers
April 11, 2017
IBA Molecular and Mallinckrodt Nuclear Medicine Merge to Become Curium
April 11, 2017 — IBA Molecular announced that it has merged with previous acquisition Mallinckrodt...
January 30, 2017
IBA Molecular Acquires Mallinckrodt Nuclear Imaging
IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced in August 2016,...
January 06, 2016
The Medicines Company Agrees to Divest Hemostasis Portfolio to Mallinckrodt
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...
July 29, 2015
Guerbet Group Acquires Mallinckrodt Contrast Media and Delivery Systems Business
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast...
The Bayer Arterion contrast injector.
Contrast Media Injectors
February 10, 2015
| Raissa Rocha and Dave Fornell
Latest Trends in Contrast Media Injectors
There have been several recent advances with contrast media injector technology, including cutting costs by reducing...
September 25, 2014
Mallinckrodt Begins U.S. Launch Of OptiSync Contrast Data Management System
Mallinckrodt announced the U.S. launch of the OptiSync data management system as a new technology in its Global Medical...
February 06, 2014
IMV Survey Finds Aging MRI Scanner Infrastructure
The average age of installed
Scranton Gillette Communications
. All Rights Reserved.
Terms and Conditions